AbbVie/United Therapeutics $350m Voucher Deal: Smart Move?

AbbVie became the latest firm to test the FDA "voucher" strategy as a pathway to success – entering into a $350m deal with United Therapeutics in an effort to get an experimental medicine to the market quicker.